Disease-A-Month
Volume 57, Issue 1 , Pages 55-68 , January 2011

Asbestos and Lung Cancer

References 

  1. Henderson DW, Rodelsperger K, Woitowitz HJ, et al. After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997-2004. Pathology. 2004;36(6):517–550
  2. WHO. Cancer fact sheet (Facts Sheet number 297 (February 2009)). http://www.who.int/mediacentre/factsheets/fs297/en/print.htmlAccessed: August 4, 2010
  3. Murray R. Asbestos: a chronology of its origins and health effects. Br J Ind Med. 1990;47(6):361–365
  4. Gloyne SR. Pneumoconiossis: a histological survey of necropsy material in 1205 cases. Lancet. 1951;1(6659):810–814
  5. Doll R. Mortality from lung cancer in asbestos workers. Br J Ind Med. 1955;12(2):81–86
  6. Selikoff IJ, Churg J, Hammond EC. Asbestos exposure and neoplasia. JAMA. 1964;188:22–26
  7. Tweedale G. Asbestos and its lethal legacy. Nat Rev Cancer. 2002;2(4):311–315
  8. Harding AH, Darnton A, Wegerdt J, et al. Mortality among British asbestos workers undergoing regular medical examinations (1971-2005). Occup Environ Med. 2009;66(7):487–495
  9. Frost G, Harding AH, Darnton A, et al. Occupational exposure to asbestos and mortality among asbestos removal workers: a Poisson regression analysis. Br J Cancer. 2008;99(5):822–829
  10. Meguellati-Hakkas D, Cyr D, Stucker I, et al. Lung cancer mortality and occupational exposure to asbestos among telephone linemen: a historical cohort study in France. J Occup Environ Med. 2006;48(11):1166–1172
  11. Sullivan PA. Vermiculite, respiratory disease, and asbestos exposure in Libby, Montana: update of a cohort mortality study. Environ Health Perspect. 2007;115(4):579–585
  12. Camus M, Siemiatycki J, Meek B. Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer. N Engl J Med. 1998;338(22):1565–1571
  13. Luo S, Liu X, Mu S, et al. Asbestos related diseases from environmental exposure to crocidolite in Da-yao, China (I. Review of exposure and epidemiological data). Occup Environ Med. 2003;60(1):35–42
  14. Reid A, Heywork J, de Klerk N, et al. The mortality of women exposed environmentally and domestically to blue asbestos at Wittenoom, western Australia. Occup Environ Med. 2008;65(11):743–749
  15. Weiss W. Asbestos-related pleural plaques and lung cancer. Chest. 1993;103(6):1854–1859
  16. Hillerdal G, Henderson DW. Asbestos, asbestosis, pleural plaques and lung cancer. Scand J Work Environ Health. 1997;23(2):93–103
  17. Hillerdal G. Pleural plaques and risk for bronchial carcinoma and mesothelioma (A prospective study). Chest. 1994;105(1):144–150
  18. Cullen MR, Barnett MJ, Balmes JR, et al. Predictors of lung cancer among asbestos-exposed men in the {beta}-carotene and retinol efficacy trial. Am J Epidemiol. 2005;161(3):260–270
  19. Banks DE, Shi R, McLarty J, et al. American College of Chest Physicians consensus statement on the respiratory health effects of asbestos (Results of a Delphi study). Chest. 2009;135(6):1619–1627
  20. Hammond EC, Selikoff IJ, Seidman H. Asbestos exposure, cigarette smoking and death rates. Ann NY Acad Sci. 1979;330:473–490
  21. Lee PN. Relation between exposure to asbestos and smoking jointly and the risk of lung cancer. Occup Environ Med. 2001;58(3):145–153
  22. Liddell FDK. The interaction of asbestos and smoking in lung cancer. Ann Occup Hyg. 2001;45(5):341–356
  23. Reid A, de Klerk NH, Ambrosini GL, et al. The risk of lung cancer with increasing time since ceasing exposure to asbestos and quitting smoking. Occup Environ Med. 2006;63(8):509–512
  24. Heintz NH, Janssen-Heininger YM, Mossman BT, et al. Lung cancers, and mesotheliomas: from molecular approaches to targeting tumor survival pathways. Am J Respir Cell Mol Biol. 2010;42(2):133–139
  25. Linardou H, Dahabreh IJ, Kanaloupiti D, et al. Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer. Lancet Oncol. 2008;9(10):962–972
  26. Nelson HH, Christiani DC, Wiencke JK, et al. k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis. Cancer Res. 1999;59(18):4570–4573
  27. Dostert C, Petrilli V, Van Bruggen R, et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science. 2008;320(5876):674–677
  28. Asbestosis WW. A marker for the increased risk of lung cancer among workers exposed to asbestos. Chest. 1999;115(2):536–549
  29. Reid A, de Klerk N, Ambrosini GL, et al. The effect of asbestosis on lung cancer risk beyond the dose related effect of asbestos alone. Occup Environ Med. 2005;62(12):885–889
  30. Ross RM. The clinical diagnosis of asbestosis in this century requires more than a chest radiograph. Chest. 2003;124(3):1120–1128
  31. Sluis-Cremer GK, Bezuidenhout BN. Relation between asbestosis and bronchial cancer in amphibole asbestos miners. Br J Ind Med. 1989;46(8):537–540
  32. Oksa P, Klockars M, Karjalainen A, et al. Progression of asbestosis predicts lung cancer. Chest. 1998;113(6):1517–1521
  33. Hessel PA, Gamble JF, McDonald JC, et al. Asbestosis, and lung cancer: a critical assessment of the epidemiological evidence. Thorax. 2005;60(5):433–436
  34. Stayner LT, Dankovic DA, Lemen RA. Occupational exposure to chrysotile asbestos and cancer risk: a review of the amphibole hypothesis. Am J Public Health. 1996;86(2):179–186
  35. Loomis D, Dement J, Richardson D, et al. Asbestos fibre dimensions and lung cancer mortality among workers exposed to chrysotile. Occup Environ Med. 2010;67(9):580–584
  36. Churg A. Lung cancer cell type and asbestos exposure. JAMA. 1985;253(20):2984–2985
  37. Lee BW, Wain JC, Kelsey KT, et al. Association of cigarette smoking and asbestos exposure with location and histology of lung cancer. Am J Respir Crit Care Med. 1998;157(3 Pt 1):748–755
  38. Karjalainen A, Anttila S, Heikkila L, et al. Lobe of origin of lung cancer among asbestos-exposed patients with or without diffuse interstitial fibrosis. Scand J Work Environ Health. 1993;19(2):102–107
  39. Weiss W. Asbestosis and lobar site of lung cancer. Occup Environ Med. 2000;57(5):358–360
  40. Guidotti TL. American Thoracic Society documents (diagnosis and initial management of nonmalignant diseases related to asbestos). Am J Respir Crit Care Med. 2004;170:691–715
  41. Vierikko T, Jarvenpaa R, Autti T, et al. Chest CT screening of asbestos-exposed workers: lung lesions and incidental findings. Eur Respir J. 2007;29(1):78–84
  42. Clin B, Morlais F, Guittet L, et al. Performance of chest radiograph and CT scan for lung cancer screening in asbestos-exposed workers. Occup Environ Med. 2009;66(8):529–534
  43. Tossavainen A. International expert meeting on new advances in the radiology and screening of asbestos-related diseases. Scand J Work Environ Health. 2000;26(5):449–454
  44. Ghosal R, Kloer P, Lewis KE. A review of novel biological tools used in screening for the early detection of lung cancer. Postgrad Med J. 2009;85(1005):358–363
  45. Lam B, Lam SY, Wong MP, et al. Sputum cytology examination followed by autofluorescence bronchoscopy: a practical way of identifying early stage lung cancer in central airway. Lung Cancer. 2009;64(3):289–294
  46. Loewen G, Natarajan N, Tan D, et al. Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment. Thorax. 2007;62(4):335–340
  47. van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med. 2009;361(23):2221–2229
  48. McAdams HP, Erasmus JJ, Patz EF, et al. Evaluation of patients with round atelectasis using 2-[18F]fluoro-2-deoxy-d-glucose PET. J Comput Assist Tomogr. 1998;22(4):601–604
  49. Henderson DW. Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution (Consensus report). Scand J Work Environ Health. 1997;23:311–316
  50. Bapoje SR, Whitaker JF, Schulz T, et al. Preoperative evaluation of the patient with pulmonary disease. Chest. 2007;132(5):1637–1645
  51. Peto R, Darby S, Deo H, et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ. 2000;321(7257):323–329
  52. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334(18):1150–1155
  53. Ak G, Metintas M, Metintas S, et al. Characteristics of lung cancer patients with asbestos-related radiological findings. Tuberk Toraks. 2008;56(3):257–265

PII: S0011-5029(10)00211-7

doi: 10.1016/j.disamonth.2010.12.005

Disease-A-Month
Volume 57, Issue 1 , Pages 55-68 , January 2011

Article Tools

* Image Usage & Resolution